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ABSTRACT
Background: The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) is a widely used
screening tool for dementia. We aimed to determine the ability of the German version of the 16-item
IQCODE with a two-year time frame to discriminate healthy mature control participants (NC) from mild
cognitive impairment (MCI) and probable early Alzheimer’s disease (AD) patients (all with Mini-mental
State Examination (MMSE) scores ≥ 24/30) and to optimize diagnostic discriminability by shortening the
IQCODE.
Methods: 453 NC (49.7% women, age = 69.5 years ± 8.2, education = 12.2 ± 2.9), 172 MCI patients (41.9%
women, age = 71.5 years ± 8.8, education = 12.3 ± 3.1) and 208 AD patients (59.1% women, age = 76.0
years ± 6.4, education = 11.4 ± 2.9) participated. Stepwise binary logistic regression analyses (LR) were used
to shorten the test. Receiver operating characteristic curves (ROC) determined sensitivities, specificities, and
correct classification rates (CCRs) for (a) NC vs. all patients; (b) NC vs. MCI; and (c) NC vs. AD patients.
Results: The mean IQCODE was 3.00 for NC, 3.35 for MCI, and 3.73 for AD. CCRs were 85.5% (NC-
patient group), 79.9% (NC-MCI), and 90.7% (NC-AD), respectively. The diagnostic discriminability of the
shortened 7-item IQCODE (i.e. items 1, 2, 3, 5, 7, 10, 14) was comparable with the longer version (i.e.
7-item CCRs: NC-patient group: 85.3%; NC-MCI: 80.1%, NC-AD: 90.5%).
Conclusions: The German 16-item IQCODE with two-year time frame showed excellent screening properties
for MCI and early AD patients. An abbreviated 7-item version demonstrated equally high diagnostic
discriminability, thus allowing for more economical screening.
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Introduction
A diagnostic criterion for dementia is evidence that
cognitive functioning has declined from a previous,
higher level. The Informant Questionnaire on
Cognitive Decline in the Elderly (IQCODE) is
a well-established and widely used informant-
based screening tool designed to estimate cognitive
decline from a previous level of functioning (Jorm
et al., 1989; Jorm, 2004). Its administration is
recommended to supplement the patient’s clinical
findings and especially in cases where direct patient
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testing is difficult (e.g. comprehension difficulties)
and for patients with very low levels of education
(Fuh et al., 1995; Senanarong et al., 2001; Perroco
et al., 2009). The IQCODE exists in two forms –
a longer 26-item and a shorter 16-item version –
and requires the informant to rate the patient’s
cognitive decline from a previous level over the
last 10 years on a five-point scale from “much
improved” (1) to “much worse” (5), where a score
of 3 represents a “no change” judgment. Its validity
has been established in longitudinal studies where
mean IQCODE scores were significantly correlated
with cognitive performance on a number of different
neuropsychological tasks (for an overview, see
Jorm, 2004). Since its inception, the IQCODE
has become one of the most frequently used and
best-studied informant-based screening tools and
has been translated into several different languages
including Dutch, French, Spanish, Italian, Thai
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and Chinese (de Jonghe et al., 1997; Law and
Wolfson, 1995; Del-Ser et al., 1997; Isella et al.,
2002; Senanarong et al., 2001; Fuh et al., 1995,
respectively).
IQCODE informants are typically required to
base their judgments of changes in the patient’s
functioning on a 10-year time interval, although a
five-year (Barba et al., 2000; Pisani et al., 2003)
or variable (Patel et al., 1993) time interval has
been used to address different questions. However,
in dementia screening, judgments of changes in a
patient’s functioning over a 10-year time interval are
often confounded by multiple changes associated
with retirement (Calero-Garcia et al., 2007).
Additionally, it may be difficult for informants to
remember patients’ cognitive performance over this
long time period (Coughlin, 1990). Given these
potential confounds, and advancements in the early
detection and treatment of dementia, a shorter
time-frame for informant judgments appears more
appropriate for the screening of dementia symptoms
with the IQCODE.
The goals of the present study were to determine
the diagnostic discriminability of the German
16-item version of the IQCODE with a two-year
observation interval to discriminate between healthy
older individuals and those with cognitive changes
impacting on daily functioning, i.e. mild cognitive
impairment (MCI) or a probable Alzheimer’s
disease (AD) patients. A two-year-observation
interval was selected for the reasons outlined above,
and corresponded to the test-retest interval of the
healthy participants in the present study, all of
whom were members of the longitudinal BASEL
study (Basel Study on the ELderly; Monsch
et al., 2000; see also Shultz et al., 1998). Since, to
our knowledge, no normative data on the German
IQCODE exist, we collected IQCODE data from
informants of healthy older participants. These
normative data allowed us to quantify the judgments
of significant others (spouses, carers, etc) regarding
changes in healthy older individuals’ cognitive
functioning and thus provided us with a baseline for
interpreting rated changes in MCI and AD patients’
cognitive functioning. To ensure that the earliest
possible stages of cognitive changes were studied,
we only included individuals with MMSE (Mini-
mental Status Examination; Folstein et al., 1975)
scores ≥ 24/30. We aimed to determine optimal cut-
off scores to discriminate healthy individuals from
both patient groups, and to determine which cut-off
scores best differentiated MCI and AD patients
from the healthy older individuals. Finally, we also
explored whether it was possible to significantly re-
duce the number of IQCODE items while retaining
its diagnostic discriminability in an attempt to de-
velop a more economical dementia screening tool.
Methods
Participants and procedures
HE A LTH Y AG E D PA RTI C I PA N T S
As part of the BASEL study (Basel Study on
the ELderly; Monsch et al., 2000), a longitudinal
study assessing cognitive performance in older
individuals, a large number of healthy individuals
(NC) were neuropsychologically tested with the
Consortium to Establish a Registry on Alzheimer’s
Disease Neuropsychological Assessment Battery
(CERAD-NAB; Morris et al., 1988; 1989; Welsh
et al., 1994) and were assessed with a detailed
medical history questionnaire. While collecting the
informant anamnesis, the accompanying significant
other of 453 NC study participants (see Table 1)
filled out the German 16-item IQCODE with a
two-year time frame. All NC participants fulfilled
the following inclusion criteria: they spoke German
as their first language; obtained z-scores ≤ −1.96
(2.5th percentile) in no more than one of the 11
CERAD-NAB variables; and were in good general
health, i.e. had no current systemic illnesses, no
psychiatric problems, no diseases interfering with
the administration of neuropsychological tests (e.g.
severe hearing or visual deficits), no diseases of the
central nervous system (CNS), no diseases or events
during life which could have negatively impacted
CNS activity; and did not suffer from depression
according to the Diagnostic and Statistical Manual of
Mental Disorders (American Psychiatric Association,
1994) as assessed with a standardized questionnaire
(Ku¨hner, 1997). See Table 1 for demographic
characteristics of the NC sample.
The project was approved by the local Ethics
Committee, and written informed consent was
obtained from all participants.
PATI E N T S W I T H MCI A N D V E RY M IL D TO
M I L D D E M E N T I A
Data from two groups of patients from the
Memory Clinic of the University Hospital Basel
were available for analysis: 215 individuals with
a diagnosis of MCI according to the Winblad
et al. criteria (2004) and 267 patients with a
diagnosis of probable AD according to the criteria
outlined by the National Institute for Neurological
and Communicative Disorders and Stroke and
the Alzheimer’s Disease and Related Disorders
Association (McKhann et al., 1984) and DSM-IV
criteria for AD (American Psychiatric Association,
1994). MCI and AD patients had undergone
extensive standardized neuropsychological testing
and medical examinations including neurological,
neuroimaging and laboratory tests as part of their
routine clinical workup (Monsch et al., 1995). To
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Table 1. Demographic characteristics of healthy mature individuals (NC), patients with mild cognitive
impairment (MCI), and patients with probable Alzheimer’s disease (AD)
NC MCI A D DIFFERENCES
(N = 453) (N = 172) (N = 208) W I T H p < 0.05†
...................................................................................................................................................................................................................................................................................................................
Age (years) ± SD 69.5 ± 8.2 71.5 ± 8.8 76.0 ± 6.4 NC < MCI < AD
Gender (% male) 50.3 58.1 40.9 MCI > AD
Education (years) ±
SD
12.2 ± 2.9 12.3 ± 3.1 11.4 ± 2.9 NC, MCI > AD
MMSE ± SD 28.9 ± 1.2 27.9 ± 1.7 26.0 ± 1.6 NC > MCI > AD
min–max 24–30 24–30 24–30
IQCODE-mean ± SD 3.00 ± 0.26 3.35 ± 0.36 3.73 ± 0.46 NC < MCI < AD
Source of information Differences with
p < 0.05†
Spouse, n (%) 330 (72.8) 121 (70.3) 119 (57.2) NC, MCI > AD
Child, n (%) 41 (9.1) 29 (16.9) 62 (29.8) NC < MCI < AD
Friend, n (%) 40 (8.8) 7 (4.1) 11 (5.3) NC > MCI
Other, n (%) 42 (9.3) 15 (8.7) 16 (7.7)
MMSE = Mini-mental State Examination (Folstein et al., 1975)
† Comparisons using t test (continuous variables) or χ2 (discrete variables).
determine the ability of the IQCODE to correctly
classify cognitively impaired individuals in the early
stage of the disease process, we only included
data from patients with MMSE scores ≥ 24/30,
i.e. in the same range as the NC participants.
The IQCODE (16 items, two-year observation
period) was completed by the informants while the
respective patient was neuropsychologically tested.
Since the NC questionnaires had no missing items,
only the IQCODE data from 172 MCI and 208
AD patients with completely filled in questionnaires
were included in the analyses.
A comparison of complete vs. incomplete
IQCODEs in the MCI group revealed that
only Item 1 received a lower mean score in
individuals with complete compared to incomplete
questionnaires (3.78 vs. 3.87; (t [209] = −2.492,
p = .013 (two-tailed)). In the AD group, there
was a difference in overall mean IQCODE score
(3.73 vs. 3.92; t [265] = −2.73, p = 0.007) as well
as lower mean scores on items 1 (3.78 vs. 4.05;
t [263] = −2.539, p = 0.012), 2 (4.10 vs. 4.33;
t [263] = −2.017, p = 0.045), 5 (3.64 vs. 3.91;
t [263] = −2.696, p = 0.007), 6 (3.82 vs. 4.07;
t [263] = −2.273, p = 0.024), 7 (4.06 vs. 4.36;
t [261] = −2.755, p = 0.006), and 12 (3.61 vs.
3.93; t [262] = −2.919, p = 0.039) for patients with
complete compared to incomplete questionnaires.
The IQCODE mean was calculated according to
standard procedures by dividing the sum of all
items by the number of completed items (cf. Jorm
2004). Thus, the estimated cognitive decline was
greater for patients with missing items on the
IQCODE in both patient groups. Importantly, the
demographic status of patients with complete vs.
incomplete questionnaires did not differ in both
groups. Because of our goal to detect cognitive
decline as early as possible, we included only
complete questionnaires in our study.
The demographic characteristics and informa-
tion regarding the informants of the final patient
groups are listed in Table 1. Of note are the mean
education levels of the final participant groups: NC
sample = 12.2 (2.9) years; MCI sample = 12.3
(3.1); AD sample = 11.4 (2.9).
Statistical analyses
Following the descriptive statistics on the mean
IQCODE score, we calculated binary logistic
regressions and receiver operating characteristic
(ROC) curves to determine the ability of the
IQCODE to discriminate between (a) the NC
and entire patient group (i.e. MCI and AD); (b)
the NC and MCI groups; and (c) the NC and
AD groups. The cut-off values in the logistic
regression were determined by the proportions of
the respective group sizes and were 0.46 (NC vs.
all patients), 0.28 (NC vs. MCI), and 0.32 (NC
vs. AD). The confidence intervals for sensitivities
and specificities were calculated following the exact
method described in Clopper and Pearson (1934).
The most common and practical IQCODE
scoring method in the clinical setting is the simple
mean score. We aimed to determine how well the
simple average of IQCODE items discriminated
healthy controls from patients in the earliest
stages of a degenerative illness compared to a
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statistically more sophisticated scoring system in
which IQCODE items were weighted according to
their diagnostic relevance. We therefore performed
a binary logistic regression analysis of all 16 items
and compared the diagnostic discriminability of this
model with that of the simple mean. Finally, a
binary logistic regression model (backward stepwise
elimination using the WALD statistic, exclusion
criterion: p = 0.10; inclusion criterion: p =
0.05) was used to identify a subset of items
which optimally differentiated NC individuals from
patients. Thus, this final model included only
significant predictors.
The areas under the ROC curves of the 16-
item and shorter IQCODE versions were compared
using Hanley and McNeil’s (1983) method to
test for differences in the correct classification of
individuals. We computed 1000 bootstrap replicates
(Efron, 1979) to estimate the variability of the cut-
off scores.
All statistical analyses were conducted with SPSS
15.0 (SPSS Inc., Chicago, IL) and the freely avail-
able software package R (www.cran.r-project.org).
Results
Using the German 16-item version of the IQCODE,
significant others rated NC participants on average
as having displayed no changes in cognitive
functioning over the two-year observation period
(IQCODE: mean 3.00, SD 0.26). The mean
IQCODE scores were 3.56 (SD 0.46) for both
patient groups combined, 3.35 (SD 0.36) for the
MCI group and 3.73 (SD 0.46) for the AD patients.
Thus, overall, cognitive changes in the preceding
two years were rated as more negative in the MCI
group than the NC group (t [240.12] = −11.81,
p < 0.0001 (two-tailed) and more negative in the
AD than the MCI patients (t [376.47] = −8.89,
p < 0.0001 (two-tailed)). Interestingly, 68% of
NC participants were rated as having exhibited
no changes or an improvement in functioning
(IQCODE mean ≤ 3.00) compared to only 15%
of MCI and 2.4% of AD patients.
The results of the binary logistic regression
analyses aiming to discriminate NC from patient
groups are shown in Table 2(a–c). This table also
lists values for the areas under the ROC curves
constructed using mean IQCODE scores, and the
corresponding optimal cut-off scores. The correct
classification rates (CCRs) of the mean 16-item
IQCODE were 85.5% for the discrimination of
NC from all patients, 79.9% for the discrimination
of NC and MCI, and 90.7% for NC vs. AD.
An analysis of the areas under the ROC curves
following Hanley and McNeil (1983) demonstrated
that the mean IQCODE (16 items) was superior
to the MMSE in its ability to discriminate NC
from all patients (z = 5.82; p < 0.0001), NC from
MCI (z = 5.36; p < 0.0001) and NC from AD
patients (z = 3.48, p < 0.001). Thus, based on
the predetermined equal weighting of sensitivity
and specificity, bootstrap resampling generated an
optimal cut-off score of 3.19 to differentiate NC
from all patients. This cut-off score was reached
by 67% of the bootstrap samples, whereas 33%
resulted in the next higher cut-off score of 3.25.
The cut-off score of 3.19 also optimally
differentiated NC from MCI individuals (88%
of bootstrap samples), whereas 10% of bootstrap
samples resulted in the next higher cut off score
of 3.25, and 2% resulted in the next smaller cut-off
score of 3.13. In the differentiation of NC from AD,
44% of bootstrap samples resulted in an optimal
cut-off score of 3.25, while 31% of bootstrap
samples generated the next higher score (3.31), 21%
the next lower score (3.19) and 3% the score of
3.38. A comparison of the areas under the ROC
curves demonstrated that the linear combination of
16 items differentiated groups as well as the mean
of the 16 items (NC vs. all patients: z = 0.10, p =
0.92; NC vs. MCI: z = 0.43, p = 0.67; NC vs. AD:
z = 0.36, p = 0.72).
To explore the possibility of generating a shorter
version of the IQCODE with high diagnostic
discriminability, we performed a binary logistic
regression with backward stepwise elimination. This
analysis resulted in an 8-item version (IQCODE
items 1, 2, 3, 4, 5, 7, 10 and 14) which
optimally distinguished NC individuals from all
patients. Since the negative weighting of Item 4
in the regression equation resulted in a rating of
“worsening” adding positively to the mean, this item
was also eliminated, such that only items 1, 2, 3,
5, 7, 10 and 14 remained in the final model (see
Table 3). The following equation best discriminated
the groups of NC and all patients: −20.051 +
(1.135∗IQ1) + (0.682∗IQ2) + (1.143∗IQ3) +
(0.694∗IQ5) + (0.713∗IQ7) + (0.616∗IQ10) +
(1.085∗IQ14) (where IQx = IQCODE-item Nr.
x). The following equation describes the optimal
differentiation of NC from MCI with these
items: −18.589 + (1.175∗IQ1) + (0.829∗IQ2) +
(0.828∗IQ3) + (0.432∗IQ5) + (0.822∗IQ7) +
(0.398∗IQ10) + (0.999∗IQ14). Finally, the optimal
differentiation of NC from AD was achieved with
the following equation: −26.809 + (1.16∗IQ1) +
(0.398∗IQ2) + (1.766∗IQ3) + (1.65∗IQ5) +
(0.418∗IQ7) + (1.063∗IQ10) + (1.393∗IQ14). By
applying these formulae to participants’ data, CCRs
of 86.4% (NC vs. all patients), 80.2% (NC vs.
MCI) and 92.0% (NC vs. AD) were reached
(see Table 2). Significantly, comparisons of AUCs
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Table 2. Diagnostic discriminability of the Mini-mental State Examination, 16-item and 7-item IQCODE as
estimated by the results of a binary logistic regression analysis (sensitivity, speciﬁcity, correct classiﬁcation rate),
areas under receiver operating characteristic curves, as well as corresponding cut-off-scores
S E N S I T I V I T Y SP E C I F I C I T Y RO C (AU C)
(95% CI) (95% CI) CCR (95% CI) CUT-O F F
...............................................................................................................................................................................................................................................................................................................................
(a) differentiation of healthy mature individuals and all patients (i.e. MCI and probable AD)
MMSE 60.8 (55.7–65.7) 88.7 (85.5–91.5) 74.8 0.806 (0.776 – 0.836) 27.5
16 item IQCODE linear combination score 80.8 (76.5–84.6) 91.2 (88.2–93.6) 86.0 0.912 (0.890 – 0.934)
Mean 16-item IQCODE 78.4 (73.9–82.5) 92.5 (89.7–94.8) 85.5 0.911 (0.889 – 0.933) 3.19
7-item IQCODE linear combination score 82.6 (78.4–86.3) 90.1 (86.9–92.7) 86.4 0.906 (0.883–0.929)
Mean 7-item IQCODE 76.1 (71.4–80.3) 94.5 (92.0–96.4) 85.3 0.907 (0.884 – 0.929) 3.43
(b) Differentiation of healthy mature individuals and patients with MCI
MMSE 57.6 (49.8 – 65.1) 70.4 (66.0–74.6) 64.0 0.677 (0.628–0.726) 28.5
16-item IQCODE linear combination score 75.0 (67.8–81.3) 89.0 (85.7–91.7) 82.0 0.854 (0.814–0.894)
Mean 16-item IQCODE 72.1 (64.8–78.7) 87.6 (84.3–90.5) 79.9 0.848 (0.808–0.888) 3.19
7-item IQCODE linear combination score 75.0 (67.8–81.3) 85.4 (81.8–88.6) 80.2 0.840 (0.798–0.883)
Mean 7-item IQCODE 75.0 (67.8–81.3) 85.2 (81.6–88.4) 80.1 0.842 (0.801–0.883) 3.29
(c) Differentiation of healthy mature individuals and patients with probable AD
MMSE 81.7 (75.8–86.7) 88.7 (85.5–91.5) 85.2 0.912 (0.889–0.936) 27.5
16-item IQCODE linear combination score 87.5 (82.2–91.7) 94.5 (92.0–96.4) 91.0 0.966 (0.949–0.983)
Mean 16-item IQCODE 88.9 (83.9–92.9) 92.5 (89.7–94.8) 90.7 0.964 (0.946–0.981) 3.25
7-item IQCODE linear combination score 89.4 (84.4–93.3) 94.5 (92.0–96.4) 92.0 0.960 (0.942–0.978)
Mean 7-item IQCODE 86.5 (81.1–90.9) 94.5 (92.0–96.4) 90.5 0.960 (0.942–0.978) 3.43
IQCODE = Informant Questionnaire on Cognitive Decline in the Elderly; MCI = mild cognitive impairment; AD = Alzheimer’s disease;
CI = Confidence interval; CCR = correct classification rate; ROC = receiver operating characteristic; AUC = area under curve; MMSE =
Mini-mental State Examination
Table 3. The 7-item IQCODE questions whose diagnostic discriminability equals that
of the longer 16-item version
1 Remembering things about family and friends, e.g. occupations, birthdays, addresses
2 Remembering things that have happened recently
3 Recalling conversations a few days later
5 Remembering what day and month it is
7 Remembering where to find things which have been put in a different place from usual
10 Learning new things in general
14 Handling financial matters, e.g. the pension, dealing with the bank
of the 16-item and 7-item linear combination
IQCODE scores demonstrated that both solutions
discriminated participant groups equally well (NC
vs. all patients: z = 0.82, p = 0.41; NC vs. MCI: z =
0.57, p = 0.57; NC vs. AD: z = 0.42, p = 0.67).
The CCR of the mean 7-item version were
85.3% (NC vs. all patients), 80.1% (NC vs. MCI)
and 90.5% (NC vs. AD) (see Table 2). Thus, no
change or an improvement in cognitive functioning
(IQCODE mean ≤ 3.00) was apparent in 70% of
NCs compared to 18% of MCI and 2.4% of AD
patients. The quality of these classifications – as
judged by an AUC comparison – was comparable
to that of the mean 16-item version (NC vs. all
patients: z = 0.60, p = 0.55; NC vs. MCI: z =
0.43; p = 0.67; NC vs. AD: z = 0.53; p = 0.60)
as well as the linear combination of the 7 IQCODE
items (NC vs. all patients: z = 0.06, p = 0.99; NC
vs. MCI: z = 0.18; p = 0.86; NC vs. AD: z = 0.72;
p = 0.47). The mean of the 7-item IQCODE was
also superior to the MMSE in discriminating NC
from all patients (z = 5.47; p < 0.0001), NC from
MCI (z = 5.13, p < 0.001) and NC from AD (z =
2.59; p < 0.01).
The internal consistencies of both versions of the
IQCODE were high (Cronbach’s α: IQCODE 16
item = 0.913; IQCODE 7 item = 0.818).
The ideal cut-off scores of the mean 7-item
IQCODE version were 3.43 (NC vs. all patients;
61% of bootstrap samples; 39% resulted in the next
smaller cut-off of 3.29), 3.29 (NC vs. MCI; 93% of
bootstrap samples; 7% resulted in the next higher
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Figure 1. Comparison of receiver operating characteristic (ROC) curves of MMSE, mean 16-item IQCODE, and mean 7-item IQCODE comparing (a) healthy mature individuals (NC) vs. all patients
(MCI and AD); (b) NC vs. MCI; and (c) NC vs. AD.
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cut-off of 3.43) and 3.43 (NC vs. AD; 98% of
bootstrap samples; 1.7% resulted in the next smaller
cut-off of 3.29, 0.3% resulted in the next higher cut-
off of 3.57).
Figure 1 shows the ROC curves of MMSE and
mean 16-item and 7-item IQCODE scores.
Discussion
The goal of our study was to determine the
diagnostic discriminability of the German short 16-
item IQCODE version with a two-year time frame in
patients with MCI and probable early AD. We also
explored whether the number of IQCODE items
could be significantly reduced without comprom-
ising its diagnostic discriminability. In general, the
IQCODE consistently correctly classified individu-
als more effectively than the MMSE, although the
MMSE demonstrated a surprisingly good perform-
ance, especially in the discrimination of NC from
early stage AD with its correct classification rate of
85%. However, the present findings demonstrate
that the short IQCODE with a two-year time frame
has excellent screening properties. Importantly, a
logistic regression analysis produced a very short 7-
item IQCODE with a diagnostic accuracy as high
as the longer version. Interestingly, all of these
seven items are also part of the Brazilian 15-item
short form of the IQCODE, recently developed by
Perroco et al. (2009) in a study of NC and AD
groups (mean MMSE = 27.9 and 19.8, respect-
ively) with low levels of education (mean education
level = 5.4 and 4.8, respectively). Moreover,
five of our seven items are also represented in
the group of the eight best discriminating items
of the Brazilian short form. These consistencies
suggest that educational level, culture and ethnicity
do not necessarily determine the selection of
optimally discriminating IQCODE items. However,
Senanarong et al. (2001) found that three IQCODE
items significantly discriminated samples of NC and
AD Thai participants with four or less years of
education. This difference, which is unlikely to be
the result of a single factor, supports our view that
absolute cross-cultural compatibility of diagnostic
instruments may not be an attainable goal.
Clearly, it will be necessary to replicate the
diagnostic performance of the 7-item version when
only these items are presented for ratings. For
both the short and very short versions, mean
IQCODE scores correctly classified individuals as
well as linear combinations of individual IQCODE
items. This impressive finding signifies that the
easily calculated IQCODE mean score need not
be replaced by a more complicated scoring system
in the clinical setting. Taken together, these results
show that compared to NC participants, patients
with MCI and an early stage of probable AD appear
to show cognitive decline in daily life to such an
extent that ratings for all three participant groups
significantly differed from one another.
Since the purpose of dementia screening is to
detect pathologic cognitive functioning as early
as possible, the more stringent cut-off scores
which discriminate NC from MCI patients appear
appropriate for both versions of the IQCODE. This
corresponds to a score of 3.19 for the mean 16-item
IQCODE version, and 3.29 for the mean 7-item
version. Higher cut-off scores for the discrimination
of NC from AD patients have been reported
for the 16-item IQCODE version (e.g. Jorm
et al., 1996; Del-Ser et al., 1997; Perroco et al.,
2009). This difference is most likely due to the
inclusion in these previous studies of patients in
more advanced stages of the disease process and
to longer IQCODE judgment intervals. Because of
the increased sensitivity of its combination of items,
the cut-off scores for the 7-item version are slightly
higher than those for the 16-item version. Thus,
further diagnostic examinations are indicated when
at least three of the 16 items, and at least two of the
seven items, are judged as “a bit worse”.
The version of the IQCODE used in the
present study instructed informants to rate target
participants’ changes in cognitive functioning over
the preceding two years. For dementia screening
with the IQCODE, longer observation periods
(e.g. 10 years) are typically used (e.g. de Jonghe
et al., 1997; Del-Ser et al., 1997; Lim et al.,
2003). However, since individuals in their early
seventies are typically referred to a memory clinic
(Rosness et al., 2009; Frisoni et al., 2009), and
since retirement usually takes place around the
age of 65 in German-speaking countries, the
common 10-year time frame requires informants
to compare patients’ current cognitive performance
during retirement with cognitive performance
during the last few years of occupational activity.
These different phases of life have different
cognitive demands (Powell, 1994; Calero-Garcia
et al., 2007) which may confound IQCODE
ratings, despite its focus on non-occupational
aspects of daily life. Moreover, informants may
have difficulty remembering patients’ performance
over the relatively long observation period of
10 years (see, for example, Coughlin, 1990).
The present choice of a two-year time frame
circumvents both of these potential confounders
without diminishing the IQCODE’s diagnostic
discriminability compared to versions with longer
observation periods mentioned above.
Other potential confounders of IQCODE ratings
exist. For example, it may be necessary to
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correct IQCODE scores for the influence of a
patient’s demographic status, as is commonly
done for many neuropsychological tests (Berres
et al., 2008). Without going into the details
of the results, we conducted a thorough set of
such analyses for the mean 16-item IQCODE
and found that demographically adjusted mean
IQCODE scores did not perform significantly
better in correct classification than the unadjusted
measures presented above. Fuh et al. (1995)
and Isella et al. (2006) also found no effect of
education in their studies. Moreover, in his review
of the variables influencing IQCODE results, Jorm
(2004) concluded that the effect of education
was “negligible”. Thus, it is unlikely that the
older age of the MCI and AD patients compared
to the NC group significantly influenced our
results. These negative findings may reflect the
informants’ unconscious subjective adjustment of
their expectations concerning the cognitive abilities
of the patient, e.g. their assumption that “it is
normal to get slower when getting older”. Thus,
the use of raw IQCODE scores represents a simple
and still very reliable scoring method in the clinical
setting. While patient’s demographic characteristics
were not associated with IQCODE ratings, future
studies will determine whether factors related
to the informant should be used to adjust
IQCODE scores. For example, informant anxiety
or depression may influence judgments (Jorm et al.,
1996), while the influence of social considerations
on IQCODE ratings – for example, whether
the informant’s goal is to obtain more caregiver
support – remain inconclusive (Del-Ser et al., 1997;
Lim et al., 2003). Other informant-related factors
appear less important, as reviewed by Jorm (2004):
“IQCODE-scores are not influenced by length or
type of relationship (Fuh et al., 1995) or by age and
education of the informant (Jorm et al., 1996)” (p.
286). Thus, the potential influence of informant-
associated factors on IQCODE judgments requires
further investigation.
To date, one major focus of studies using
the IQCODE has been differentiating healthy
individuals from those with a possible dementia
syndrome. The present study shows that the
IQCODE also effectively differentiates MCI from
healthy performance, consistent with previous
reports (Isella et al., 2002; 2006). While the present
NC-MCI cut-off scores require confirmation in
a longitudinal study comparing the baseline
performance of NC and MCI patients who convert
to AD, they suggest that the IQCODE is an
effective screening tool for individuals in the very
early stages of the disease process. Such screening
allows for further diagnostic examinations and
implementation of therapies early in the course of
the disease, when they are expected to have their
maximal benefit. Considering the pressing need for
new AD therapies, the earliest possible diagnosis
of this syndrome in the MCI stage is of central
importance as it identifies individuals for testing
new therapeutic interventions.
One caveat of the present study is the
inclusion criterion that patients’ IQCODES were
completely filled in, and thus, strictly speaking,
the reported results can only be applied to complete
questionnaires. Upon comparing complete and
incomplete questionnaires, we found that negative
cognitive changes were rated as more pronounced
in some items in patients (especially those with AD)
with incomplete IQCODEs. Since our goal was
to detect cognitive change as early as possible, we
decided to use only complete cases in the search for
a subset of best differentiating items. Nevertheless,
we performed an additional set of analyses
comparing models of complete with combined
complete and incomplete data, where missing values
were estimated with multiple imputation methods
(which assume that missing data can be modeled
as random, an assumption not met in our data).
These models produced essentially the same results
as those based on complete questionnaires. We
recognize that complete questionnaires may be
difficult to obtain in clinical practice. The common
method of calculating the IQCODE mean by
dividing the item sum by the number of completed
items (Fuh et al., 1995; Perroco et al., 2009),
although clinically useful, may underestimate a
patient’s deterioration in cognitive functioning.
Given these problems associated with missing items,
it is advisable to ask significant others to fill in the
missing items to the best of their knowledge. It
remains to be determined whether the short version
of the IQCODE is also able to detect early cognitive
changes associated with depression and other non-
AD causes of dementia such as vascular dementia,
Parkinson’s disease dementia, and frontotemporal
lobar degeneration.
The collection of informant information is neces-
sary whenever factors such as sensory disturbances,
severe somatic diseases and reduced compliance
(e.g. based on diminished insight) minimize or
prohibit the ability to collect direct information
while working with the patient (cf. Jorm, 2004).
These judgments of changes eliminate the need
for a premorbid evaluation and avoid the special
challenges inherent in interpreting longitudinal
findings which are influenced by learning effects
and “test sophistication” (Anastasi, 1981) during
repeated testing. Moreover, the informant-based
questionnaire of change circumvents difficulties
associated with detecting changes in the test
performance of high functioning individuals whose
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subtle changes can be overlooked when they result
in still normal test performance.
Ideally, screening instruments should be sens-
itive, specific, socially acceptable, inexpensive and
brief (Parker and Philp, 2004). In particular, the
time expended on data acquisition is becoming
an increasingly important factor in many health
systems. Primarily because previous informant-
based questionnaires on cognitive changes were
deemed too time-consuming, Galvin et al. (2005)
developed the 8-item AD8, a brief informant
interview to detect dementia. Here we demonstrate
that the IQCODE can be reduced from 16 to 7
items with no loss in diagnostic accuracy, thereby
obviating the concern expressed by Galvin et al.
regarding the length of the IQCODE. Thus, the
short 7-item version of the IQCODE with its high
diagnostic discriminability provides clinicians with
an excellent tool for screening for AD and its MCI
prodrome.
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